Parkinson’s disease augments risk of developing skin cancer melanoma


People undergoing movement disorder Parkinson’s disease may augment risk of developing skin cancer melanoma and vice-a-versa. Investigators from Mayo Clinic originate that all patients with Parkinson’s were approximately four times more likely to have a history of melanoma than those without Parkinson’s.

High-fat diet in pregnancy may increase breast cancer risk

Oppositely people with melanoma had superior risk of developing Parkinson’s. The squad examined the occurrence of melanoma in 974 patients contrast with 2,922 without.

Some former studies have recommended that a drug for Parkinson’s — known as levodopa — may be concerned in malignant melanoma, but some have originated a connection between the two diseases inspite of levodopa treatment.

The study exposed a connection between Parkinson’s disease and melanoma but argue next to levodopa as the cause. The researchers further conveyed that, it was probable that ordinary environmental, genetic or immune system irregularities underlie equally conditions in patients who have both, but more study was required to verify that and refine screening recommendations.

Lead author Lauren Dalvin from Mayo Clinic has also conveyed that, the connection between Parkinson’s disease and melanoma, will better capable to counsel patients and families about their risk of rising one disease in the setting of the other.

Heartburn drugs may put at an augmented death risk

Dalvin further added that, study should focus on recognizing common genes, immune responses and environmental experience that may connect these two diseases.